___

• 1. Nelson WE, Behrman RE, Kliegman RM, Arvin AM, editors. The Textbook of Pediatrics. 15 th edition. Philadelphia: WB Sounders Company, 1996.
• 2. Scaglione F. Predicting the clinical efficacy of antibiotics: toward definitive criteria. Pediatr Infect Dis J 1997; 16:556- 9.
• 3. Schentog JJ. Clinical significance of antibiotics tissue penetration. Clin Pharmacokinet 1989; 16(suppl 1): 25-31.
• 4. Drusano GL. Role of pharmacokinetics in outcome of infections. Antimicrob Agents Chemother 1988; 32:289-97.
• 5. Pichichero ME. Empiric antibiotic selection criteria for respiratory infections in pediatric practice. Pediatr Infect Dis J 1997; 16:560-4.
• 6. Dagan R, Schvartzman P, Liss Z. Variation in acceptance of common oral antibiotic suspensions. Pediatr Infect Dis J 1994; 13:689-90.
• 7. Hacımustafaoğlu M, Çelebi S, Sağlam H, Ercan ı, Çakar N, Yıldız Z. Çocuklarda ayaktan enfeksiyon tedavisinde antibiyotiklerin tolere edilmesi ve klinik yanıtların değerlendirilmesi. XXXV.Ulusal Pediatri Kongresi Özet Kitabı, 19-23 Mayıs, 1999, Ankara.
• 8. O. Kayaalp. Rasyonel tedavi yönünden t›bbi farmakoloji. 7.Baskı, Güneş Kitabevi, 1994, Ankara.
• 9. Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation. 4th edition. Baltimore: Williams and Wilkins, 1994.
• 10. Moellering RC. Principles of Anti ‹nfektive Therapy. In: Mandell GL, Bennett JE, Dolin R, (eds). Principles and Practice of Infectious Diseases, 4th edition, New York: Churchill Livingstone, 1995: 205-6.
• 11. Gilbert DN, Moellering RC, Sande MA. Guide to antimicrobial therapy. 28 th edition. Vienna: Sanford Guide; 1998.
• 12. American Academy of Pediatrics. Peter G, ed. 1997 Red Book: Report of the committee on Infectious Diseases. 24 th ed. Elk Grove Village, IL: American Academy of Pediatrics; 1997: 410-9, 593-603.
• 13. Gerding DN, Hughes CE, Bamberger DM, Foxworth J, Larson TA. Extravascular antimicrobial distribution and the respective blood concentrations in humans. In: Lorian V, (ed.). Antibiotics in Laboratory Medicine. 4th edition. Baltimore: Williams and Wilkins, 1996: 835-99.
• 14. Giamarelly H, Kolokythas E, Petrikkos G, Garis J, Aravantinos D, Sfikakis P. Pharmacokinetics of three newer quinolones in pregnant and lactating women. Am J Med 1989 87: (Suppl 5A): 495-515.
• 15. Bergan T, Engeset A, Olzewski W, et al. Extravascular penetration of highly protein bound flucloxacillin. Antimicrob Agents Chemother 1986; 30:729-32.
• 16. Gerding DN, Peterson LR. Serum protein binding and extravascular distribution of antimicrobials. Antimicrob Agents Chemother 1985; 15:136-8.
• 17. Wise R, Gillert AP, Cadge B, Durhan SR, Bater S. The influence of protein binding upon tissue fluid levels of six beta lactam antibiotics. J Infect Dis 1980; 142: 77-82.
• 18. Rolinson GN, The significance of protein binding of antibiotics in bacterial chemotherapy. J Antimicrob Chemother 1980; 6:311-7.
• 19. Scaglione F, Raichi M Fraschini F. Serum protein binding and extravasculer diffusion of methixyimino cephalosporins. J Antimicrob Chemother 1990; 26(Suppl A): 1-10.
• 20. Wise R. The clinical relevance of protein binding and tissue concentrations in antimicrobial therapy. Clin Pharmacokinet 1986; 11:470-82.
• 21. Ryan DM, Cars O, Hoffstedt B. The use of antibiotic serum levels to predict concentrations in tissues. Scand J Infect Dis 1986; 18: 381-8.
• 22. Rosenfeld RM. An evidence based approach to treating otitis media. Pediatr Clin North Am 43; 1996: 1165-81.
• 23. Jacobs MR. Penicillin resistant S. Pneumoniae in acute otitis media. Pediatr Infect Dis J 1998; 17:947-52.
• 24. Yuk JH, Nightingale GH, Quintitiani R. Clinical pharmacokinetics of ceftriaxone. Clin Pharmacokinet 1989; 17:223-35.
• 25. Fraschini F, Scaglione F, Pintucci G et al.The diffusion of clarithromycin and roxithomycin into nasal mucosa, tonsil and lung in humans. J Antimicrob Chemother 1991; 27: (suppl A):61-5.
• 26. Martin JR, Johnson P, Miller MF. Reuptake, accumulation and egress of erytromycin by tissue culture cells of human origin. Antimicrob Agents Chemother 1985; 27: 314-9.
• 27. Amsterdam D. Susceptibility testing of antimicrobials in liquid media. In: Lorian V (ed.). Antibioics in Laboratory Medicine. 4 th edition. Baltimore: Williams and Wilkins. 1996
• 28. Grayson MC, Elioponlos GM, Ferrano MJ, Moellering RC. Effect of varying pH on the susceptibility of Campylobacter pylori to antimicrobial agents. Eur J Clin Microbiol Infect Dis 1989; 8:888-9.
• 29. Sable CA, Scheld NM. Theoretical and practical considerations of antibiotic therapy for bacterial meningitidis. J Antibiotic Chemother 1992; 45:96-117.
• 30. Ream TRJr, Allen JC. Blood, brain and cerebrospinal fluid concentrations of several antibiotics in rabbits with intact and inflame meninges. Antimicrob Agents Chemother 1977;12: 710-6.
• 31. Johnson CC. Invitro testing: Correlation of bacterial susceptibility, body fluid levels and effectiveness of antimicrobial therapy. In: Lorian V (ed.). Antibiotics in Laboratory Medicine. 4 th edition. Baltimore: Williams and Wilkins. 1996: 813-34.
• 32. Schuler C, Golper TA, Bennett WM. Prescribing drugs in renal disease. In: Brenner BM, (ed.). The Kidney. 5 th edition. Philadelphia: WB Sounders Company, 1996:658-89.